Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

ACTION OF MERCUROCHROME-220 ON THE GONOCOCCUS

ACTION OF MERCUROCHROME-220 ON THE GONOCOCCUS In a recent paper, Young, White and Swartz 1 presented the results of laboratory and clinical trials of mercurochrome-220, the first drug of the mercurochrome series to be extensively investigated. The laboratory work included in their paper comprises tests of the germicidal power of this drug against B. coli and Staphylococcus aureus. These tests were performed with a slight modification of the usual method for testing germicides, based on that recommended by Rideal and Walker.2 The results showed a strikingly high germicidal power for this drug, with the further fact that its maximum action occurs in a short time. This characteristic distinguishes it from certain other drugs, such as the flavines, to secure the maximum effect of which contact must be maintained over a much longer period. The new drug received clinical trials in this institute in cystitis, pyelitis, urethritis and venereal ulcerations. Its use in urethritis had to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

ACTION OF MERCUROCHROME-220 ON THE GONOCOCCUS

JAMA , Volume 76 (13) – Mar 26, 1921

Loading next page...
 
/lp/american-medical-association/action-of-mercurochrome-220-on-the-gonococcus-veIL7e5CXz
Publisher
American Medical Association
Copyright
Copyright © 1921 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1921.02630130014004
Publisher site
See Article on Publisher Site

Abstract

In a recent paper, Young, White and Swartz 1 presented the results of laboratory and clinical trials of mercurochrome-220, the first drug of the mercurochrome series to be extensively investigated. The laboratory work included in their paper comprises tests of the germicidal power of this drug against B. coli and Staphylococcus aureus. These tests were performed with a slight modification of the usual method for testing germicides, based on that recommended by Rideal and Walker.2 The results showed a strikingly high germicidal power for this drug, with the further fact that its maximum action occurs in a short time. This characteristic distinguishes it from certain other drugs, such as the flavines, to secure the maximum effect of which contact must be maintained over a much longer period. The new drug received clinical trials in this institute in cystitis, pyelitis, urethritis and venereal ulcerations. Its use in urethritis had to

Journal

JAMAAmerican Medical Association

Published: Mar 26, 1921

There are no references for this article.